These different complementary interventions were reported to be successful, with the dysmetabolic impairment found to be significantly reduced (6, 7, 9, 10, 19, 27)
Professional monitoring catches problems early
According to clinical trials, prescription GLP-1 medications typically lead to 518% weight loss, while studies of high-dose tirzepatide combined with intensive lifestyle support have reported reductions of up to ~25%
La Agencia Espaola de Medicamentos y Productos Sanitarios (Aemps) ha autorizado el uso en Espaa del antiglucmico Wegovy para el control de peso como medida para paliar los problemas de suministro de los medicamentos anlogos del GLP-1
Who Should Consider GLP-1 Therapy and Medical Evaluation GLP-1 therapy may be appropriate for individuals with type 2 diabetes, prediabetes, or obesity-related metabolic dysfunction who also have hypertension
You will feel the effects of appetite suppression immediately